Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(50%)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Terminated(1)

Detailed Status

Active, not recruiting1
Recruiting1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting125%
recruiting125%
not_yet_recruiting125%
terminated125%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

Clinico-biological Data Collection Study of Metastatic Breast Cancer

NCT03958136
not_yet_recruiting

Prevalence of Central Neuropathic Pain After a Stroke in Patients Attending Post-stroke Consultations in the Île-de-France Region

NCT06813391
recruiting

PRO Survivorship Concerns ITA

NCT06080607
terminated

TAURAS - T790 AURA ScreenFailure SOC Registry Study

NCT02405247

Clinical Trials (4)

Showing 4 of 4 trials
NCT03958136Not Applicable

Clinico-biological Data Collection Study of Metastatic Breast Cancer

Active Not Recruiting
NCT06813391

Prevalence of Central Neuropathic Pain After a Stroke in Patients Attending Post-stroke Consultations in the Île-de-France Region

Not Yet Recruiting
NCT06080607

PRO Survivorship Concerns ITA

Recruiting
NCT02405247

TAURAS - T790 AURA ScreenFailure SOC Registry Study

Terminated

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4